It is my great pleasure to inform all of you that our EPUII has recently gone through the beta testing phase in Chinese with flying colors. I would also like to take this opportunity to let you know that we are all set to enter the alpha testing stage of the EPU II in Japanese. With China and Japan being two of the leading markets across the globe for robotics, this is certainly an important developmental landmark for Emoshape.
Ever since the announcement of the Made in China 2025 plan in 2015, China has made strong strides towards emerging as the global hotspot for robotics. The International Federation of Robots also informs that China is already home to the largest share of robots across the globe. Moreover, a report by IFR suggests that by the year 2019, China is expected to account for 40 percent of the total global sales for robots. Amongst the sales markets for robots, Japan ranks third in the world after China and South Korea. More information about the about the emergence of robotics in China (and Japan) can be found at https://www.cnbc.com/2017/09/06/chinas-blueprint-to-crush-the-us-robotics-industry.html
Passing the Chinese beta testing is key to our aspirations to become a leading player in the world’s most rapidly growing robotics market. As informed earlier, we have already managed to grab the attention of some of the leading industry publications in both China and Japan. Please stay tuned for more exciting news and updates.